Obtaining Recognition for Participating in Team Science. Daniel Lackland



Similar documents
RPB RESEARCH SABBATICAL GRANT

CSER & emerge Consor.a EHR Working Group Collabora.on on Display and Storage of Gene.c Informa.on in Electronic Health Records

Alcoholism and Aging

9/21/15. Research Educa4on Solu4ons A NEW LANGUAGE FOR LEADERSHIP TRANSFORMING PERFORMANCE MANAGEMENT: AN ELI LILLY CASE STUDY

Alcohol Brief Counseling in the United States Air Force: An Air Force- Penn State Clearinghouse Collabora;ve Project

Workshop #1. Structuring complex partnered research projects and proposals

Program Model: Muskingum University offers a unique graduate program integra6ng BUSINESS and TECHNOLOGY to develop the 21 st century professional.

Why do we do what we do?

Research in Simulation: Research and Grant Writing 101

Mission. To provide higher technological educa5on with quality, preparing. competent professionals, with sound founda5ons in science, technology

Dr. Tina Parkman LPC, CAADC 7 points to Total Recovery!

Public Hearing for Consolida4ng the Small Schools Model for Improved Quality and Efficiency South Atlanta Educa4onal Complex

Pragmatic Evidence Based Review Substance Abuse in moderate to severe TBI

Dewar COEHS Meeting Documentation Form

AstroFIt Astronomy Fellowship in Italy FP- 7 Grant Agreement n

How To Treat A Drug Addiction

Pa"ent Reported Outcomes Useful for Whom? Industry s Perspec/ve. Pri/ Jhingran, Ph.D. GlaxoSmithKline

The Importance of Intellectual Property Management in Universi9es and Public Research Organiza9ons The Brazilian Experience

Na#onal Asbestos Forum 2013: Advance in Medical Research on Asbestos- Related Diseases

Examining the Propensity to Adopt Telehealth Technologies to Deliver Substance Abuse Treatment & Recovery Services

USE OF EXPERT WITNESSES IN CONTESTED CASES BY: JAMES (DUSTY) JOHNSTON GENERAL COUNSEL TEXAS BOARD OF NURSING

Interna'onal Standards Ac'vi'es on Cloud Security EVA KUIPER, CISA CISSP HP ENTERPRISE SECURITY SERVICES

Identifying High and Low Risk Practice Areas and Drugs of Choice of Chemically Dependent Nurses

The model of SWOT-analysis is the most

Pu?ng B2B Research to the Legal Test

The Development of Cloud Interoperability

Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center

16 Rankings On First Page. 30 Total Keywords. KEYWORD RANKINGS We are tracking Benchmark Date and Current Ranking. Ranking Changes Improved

The Changing Face of Opioid Addiction:

Substance Abuse and Child Welfare Practice

Brian Robinson MS ATC. Former Head Athle.c Trainer; Glenbrook South High School Faculty; Northern Illinois University

The importance of supply chain

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry

How Integrated Case Management Helps Individuals with Complex Substance Use

Big Data for Small Places ANALYTICS CAPACITY- BUILDING FOR COMMUNITY DEVELOPMENT DR. NELSON P. ROGERS, COMMUNITY INGENUITY

NSF/Intel Partnership on Cyber- Physical Systems Security and Privacy (CPS- Security)

THIRD MODULE DETERMINERS AND CONDITIONERS OF NON PRESCRIPTIVE DRUGS AND CONSUME.

Floods as a One Health Problem

Our faculty has been hand-picked for their knowledge, experience, and enthusiasm for teaching

Operational Definition for Evidence-Based Practices Addictions and Mental Health Division September 11, 2007

Peer-to-Peer Substance Abuse Education Program

About the Board. Minnesota Board of Behavioral Health and Therapy 10/24/12. Minnesota Board of Behavioral Health and Therapy

TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013

Signs of Substance Abuse in Broward County, Florida

States In Brief. The National Survey on Drug Use and Health. texas. Prevalence of Illicit Substance 1 and Alcohol Use

Ima Okonny. Acting Director Data Management & Reporting Division Research and Evaluation Branch Citizenship and Immigration Canada

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma

Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.

Drug Abuse Trends Minneapolis/St. Paul, Minnesota

Transcription:

Obtaining Recognition for Participating in Team Science Daniel Lackland

Manuscript Authorship for Team Research

What is significant authorship?

The sequence- determines- credit approach The sequence of authors reflects the declining importance of their contribu8on Authorship order only reflects rela8ve contribu8on, whereas evalua8on commi>ees o?en need quan8ta8ve measures. First author should get credit for the whole impact (impact factor), the second author half, the third a third, and so forth, up to rank ten. When papers have more than ten authors, the contribu8on of each author from the tenth posi8on onwards is then valuated just 5%.

The equal contribu8on norm Authors use alphabe8cal sequence to acknowledge similar contribu8ons or to avoid disharmony in collabora8ng groups. Contribu8on of each author is valuated as an equal propor8on (impact divided by the number of all authors, but a minimum of 5%).

The first- last- author- emphasis norm In many labs, the great importance of last authorship is well established. First author should get credit of the whole impact, the last author half, and the credit of the other authors is the impact divided by the number of all authors

The percent- contribu8on- indicated approach There is a trend to detail each author s contribu8on This should also be used to establish the quan8fied credit.

Significant Contribu8on to Science as a Team Member Team Science

A. Personal Statement Briefly describe why you are well- suited for your role in the project described in this applica8on. The relevant factors may include aspects of your training; your previous experimental work on this specific topic or related topics; your technical exper8se; your collaborators or scien<fic environment; and your past performance in this or related fields (you may men8on specific contribu8ons to science that are not included in Sec8on C).

A. Personal Statement I have the exper<se, leadership, training, exper<se and mo<va<on necessary to successfully carry out the proposed research project and coordinate the team. I have a broad background in psychology, with specific training and exper<se in ethnographic and survey research and secondary data analysis on psychological aspects of drug addic<on. My research includes neuropsychological changes associated with addic<on. As PI or co- Inves<gator on several university- and NIH- funded grants, I laid the groundwork for the proposed research by developing effec<ve measures of disability, depression, and other psychosocial factors relevant to the aging substance abuser, and by establishing strong <es with community providers that will make it possible to recruit and track par<cipants over <me as documented in the following publica<ons. In addi<on, I successfully administered the projects (e.g. staffing, research protec<ons, budget), collaborated with other researchers, and produced severalmul<- author peer- reviewed publica<ons from each project. As a result of these previous experiences, I am aware of the importance of frequent communica<on among project members and of construc<ng a realis<c team- based research plan, <meline, and budget. The current applica<on builds logically on my prior work. During 2005-2006 my career was disrupted due to family obliga<ons. However, upon returning to the field I immediately resumed my research projects and collabora<ons and successfully competed for NIH support. 1. Merryle, R.J. & Hunt, M.C. (2004). Independent living, physical disability and substance abuse among the elderly. Psychology and Aging, 23(4), 10-22. 2. Hunt, M.C., Jensen, J.L. & Crenshaw, W. (2007). Substance abuse and mental health among community- dwelling elderly. Interna<onal Journal of Geriatric Psychiatry, 24(9), 1124-1135. 3. Hunt, M.C., Wiechelt, S.A. & Merryle, R. (2008). Predic<ng the substance- abuse treatment needs of an aging popula<on. American Journal of Public Health, 45(2), 236-245. PMCID: PMC9162292 4. Hunt, M.C., Newlin, D.B. & Fishbein, D. (2009). Brain imaging in methamphetamine abusers across the life- span. Gerontology, 46(3), 122-145.

C. Contribu8on to Science Briefly describe up to five of your most significant contribu8ons to science. For each contribu8on, indicate the historical background that frames the scien8fic problem; the central finding(s); the influence of the finding(s) on the progress of science or the applica8on of those finding(s) to health or technology; and your specific role in the described work. For each of these contribu8ons, reference up to four peer- reviewed publica8ons or other non- publica8on research products (can include audio or video products; patents; data and research materials; databases; educa8onal aids or curricula; instruments or equipment; models; protocols; and so?ware or netware) that are relevant to the described contribu8on. The descrip8on of each contribu8on should be no longer than one half page including figures and cita8ons. Also provide a URL to a full list of your published work as found in a publicly available digital database such as SciENcv or My Bibliography, which are maintained by the US Na8onal Library of Medicine.

C. Contribu8on to Science 1. My early publica<ons directly addressed the fact that substance abuse is oben overlooked in older adults. However, because many older adults were raised during an era of increased drug and alcohol use, there are reasons to believe that this will become an increasing issue as the popula<on ages. These publica<ons found that older adults appear in a variety of primary care secngs or seek mental health providers to deal with emerging addic<on problems. These publica<ons document this emerging problem but guide primary care providers and geriatric mental health providers to recognize symptoms, assess the nature of the problem and apply the necessary interven<ons. By providing evidence and simple clinical approaches, this body of work has changed the standards of care for addicted older adults and will con<nue to provide assistance in relevant medical secngs well into the future. I served as the primary inves<gator or co- inves<gator or team member in all of these studies. a. Gryczynski, J., Shab, B.M., Merryle, R., & Hunt, M.C. (2002). Community based par<cipatory research with late- life addicts. American Journal of Alcohol and Drug Abuse, 15(3), 222-238. b. Shab, B.M., Hunt, M.C., Merryle, R., & Venturi, R. (2003). Policy implica<ons of gene<c transmission of alcohol and drug abuse in female nonusers. Interna<onal Journal of Drug Policy, 30(5), 46-58. c. Hunt, M.C., Marks, A.E., Shab, B.M., Merryle, R., & Jensen, J.L. (2004). Early- life family and community characteris<cs and late- life substance abuse. Journal of Applied Gerontology, 28(2),26-37. d. Hunt, M.C., Marks, A.E., Venturi, R., Crenshaw, W. & Ratonian, A. (2007). Community- based interven<on strategies for reducing alcohol and drug abuse in the elderly. Addic<on, 104(9), 1436-1606. PMCID: PMC9000292

C. Contribu8on to Science 2. In addi<on to the contribu<ons described above, with a team of collaborators, I directly documented the effec<veness of various interven<on models for older substance abusers and demonstrated the importance of social support networks. These studies emphasized contextual factors in the e<ology and maintenance of addic<ve disorders and the disrup<ve poten<al of networks in substance abuse treatment. This body of work also discusses the prevalence of alcohol, amphetamine, and opioid abuse in older adults and how networking approaches can be used to mi<gate the effects of these disorders. a. Hunt, M.C., Merryle, R. & Jensen, J.L. (2005). The effect of social support networks on morbidity among elderly substance abusers. Journal of the American Geriatrics Society, 57(4), 15-23. b. Hunt, M.C., Pour, B., Marks, A.E., Merryle, R. & Jensen, J.L. (2005). Aging out of methadone treatment. American Journal of Alcohol and Drug Abuse, 15(6), 134-149. c. Merryle, R. & Hunt, M.C. (2007). Randomized clinical trial of co<nine in older nico<ne addicts. Age and Ageing, 38(2), 9-23. PMCID: PMC9002364

Summary Team Science contribu8ons can be iden8fied as significant with appropriate jus8fica8on and detail. The Team Science contribu8on will be con8nue to be important and recognized.